Advertisement

Topics

Gerresheimer Group GmbH Company Profile

21:43 EST 13th December 2018 | BioPortfolio

The Gerresheimer Group is a leading international specialist in high-quality packaging and system approaches, particularly for the pharmaceutics and cosmetics industries. The company develops and manufactures a comprehensive product range of products made of tubular glass and special container glass, as well as packaging and application systems made of glass and plastic. State-of-the-art technologies are used to meet the most demanding customer requirements in terms of quality and precision.

Location

Benrather Straße 18-20
Düsseldorf
D-40213
Germany

Contact

Phone: 49 (0)211 / 6181-251
Fax: 49 (0)211 / 6181-241
Email: b.lingenberg@gerresheimer.com


News Articles [1022 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Gerresheimer AG (deutsch)

Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Gerresheimer AG Gerresheimer AG: Veröffentlichung gemäß § 40 Abs....

Gerresheimer: Umsatzwachstum soll sich durch neues Geschäftsfeld mittelfristig beschleunigen - Kaufen!

Frankfurt am Main (www.aktiencheck.de) - Gerresheimer-Aktienanalyse von Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktien...

Gerresheimer: Vorgelegte Geschäftszahlen und Übernahme treiben den Kurs an!

Zu den größten Gewinnern im MDAX zählte zuletzt die Aktie des deutschen Verpackungsspezialisten Gerresheimer AG (früher: Gerresheimer Glas). Anscheinend konnten sowohl die vorgelegten Geschäftsza...

Gerresheimer AG Aktie: Kaufen - Trendwechsel nach oben vollzogen!

Chartanalyse der Gerresheimer AG - Aktie Die Gerresheimer AG Aktie bewegte sich in einem intakten Abwärtstrendkanal, in dessen Verlauf sie nach oben ausgebrochen ist. Dieser Ausbruch verbunden mit...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

DGAP-News: Gerresheimer AG: Dietmar Siemssen wird Vorstandsvorsitzender der Gerresheimer AG (deutsch)

Gerresheimer AG: Dietmar Siemssen wird Vorstandsvorsitzender der Gerresheimer AG DGAP-News: Gerresheimer AG / Schlagwort(e): Personalie Gerresheimer AG: Dietmar Siemssen wird Vorstandsvorsitzender...

DGAP-News: Gerresheimer AG: Mikropumpe für die Parkinson-Therapie der Gerresheimer Tochter Sensile Medical erhält europäische CE-Deklaration (deutsch)

Gerresheimer AG: Mikropumpe für die Parkinson-Therapie der Gerresheimer Tochter Sensile Medical erhält europäische CE-Deklaration DGAP-News: Gerresheimer AG / Schlagwort(e): Markteinführung/Zulass...

Dietmar Siemssen appointed new CEO of Gerresheimer

Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, 2018. The Supervisory Board of Gerresheimer AG approved the decision in its meeting. ...

PubMed Articles [1754 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

Hemoadsorption does not Affect Hemolysis During Cardiopulmonary Bypass.

Cardiopulmonary bypass (CPB) induces hemolysis, which manifests as plasma free hemoglobin. We investigated in a post hoc analysis of a single-center, blinded, controlled study whether the use of a nov...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

Clinical Trials [4160 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Topography-Guided Customized PRK Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism

This study will include patients who will undergo PRK in both eyes, for each patient each eye will be randomly allocated to one of 2 procedures: topography-guided ablation in one eye (gro...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Application of Tachosil During Lymphadenectomy

The prevention of lymphoceles was assessed using collagen patch coated with the human coagulation factors (TachoSil, Nycomed International Management GmbH, Zurich, Switzerland; NCT Number ...

Companies [2172 Associated Companies listed on BioPortfolio]

Gerresheimer Group GmbH

The Gerresheimer Group is a leading international specialist in high-quality packaging and system approaches, particularly for the pharmaceutics and cosmetics industries. The company develops and manu...

Gerresheimer AG

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma & healthcare industry. Our wide product spectrum ranges f...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Gerresheimer Group GmbH" on BioPortfolio

We have published hundreds of Gerresheimer Group GmbH news stories on BioPortfolio along with dozens of Gerresheimer Group GmbH Clinical Trials and PubMed Articles about Gerresheimer Group GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gerresheimer Group GmbH Companies in our database. You can also find out about relevant Gerresheimer Group GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record